| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8711675 | Annals of Allergy, Asthma & Immunology | 2018 | 31 Pages |
Abstract
Common HPEAIs have a high risk of periosteal or intraosseous penetration in children and subcutaneous injections in overweight and obese adults. LPEAIs have some risk of subcutaneous injection in adults. HPEAIs with 0.1âmg of epinephrine and shorter needles have no risk of periosteal or intraosseous injection but have a high risk of subcutaneous deposit. For adult or overweight or obese patients, HPEAIs and LPEAIs should have longer needles. Future studies should focus on triggering pressures and variations in needle length.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Sten MD, PhD, Laura BSc, Gina MD, Harold MD,